NNovo Nordisk Read More Novo Nordisk (NVO) Reports Strong Weight-Loss Results for Higher-Dose Wegovy2026-05-13 Novo Nordisk (NYSE:NVO) unveiled new clinical data on Tuesday showing that a higher 7.2 mg dose of Wegovy…
NNovo Nordisk Read More EU Approves Novo Nordisk’s Higher-Dose Wegovy for Obesity Patients2026-02-20 Novo Nordisk NVO announced that the European Commission (EC) has approved a new 7.2 mg once-weekly maintenance dose of…
NNovo Nordisk Read More EU Approves Novo Nordisk’s Higher-Dose Wegovy for Obesity Patients2026-02-19 Novo Nordisk NVO announced that the European Commission (EC) has approved a new 7.2 mg once-weekly maintenance dose of…